Embryo transfer is a crucial step in completing the procedures of embryo cryopreservation, in vitro fertilization and transgenic animal production. The success of ET is in uenced by various factors; among which are operational skills, the type and the composition of anaesthetic agents used, and postoperative care. Many factors affect the response of rodents to anaesthetics. Such factors include sex, age, species, strain, weight, percentage of body fat health and
environmental temperature during recovery (Arras et al. 2001) . Several anaesthetic agents are used in mouse surgery. Ketamine is commonly used in many laboratory species as anaesthesia (Re netti & Carlisle 1988 -89, Papaioannou & Fox 1993 . Combined administration of ketamine and xylazine (Rompun) is used increasingly for safe and effective anaesthesia of laboratory animals (Mulder & Mulder 1979 , Bagis et al. 2002a . Tribromoethanol, also known as 'Avertin', has been used as a general anaesthetic in the generation of transgenic mice (Robertson 1987 , Hogan et al. 1994 , Pinkert 1994 , Gardner et al. 1995 . Many commonly used anaesthetics cause hypothermia by inhibiting central and peripheral thermoregulatory mechanisms (Wixson et al. 1987) . Intraperitoneal administration of ketamine/ xylazine and tribromoethanol produced dosedependent hypothermia of the experimental animals (Lin et al. 1987) . The aim of our study was to evaluate whether hypothermia caused by anaesthetics after ET operation could be overcome by postoperative incubation of the foster mothers, and to explore its effect on implantation rates.
Materials and methods

Animals, superovulation and embryo collection
Chemicals were purchased from Sigma Chemical Co. (St Louis, MO), unless otherwise indicated. All animals were supplied by the Iffa Credo laboratory (les Oncins, France). All animal care and use procedures were in accordance with the International Guide for the Care and Use of Laboratory Animals and were approved by TUBITAK, the Research Institute of Genetic Engineering and Biotechnology (RIGEB) Animal Care and Use Committee. Hybrid (BALB/c C57BL/6J) CB6F1 mice of 4 -5 weeks old were used as embryos donors. The animals were kept in an animal house under a 14:10 h light/dark cycle (lights on at 05:00 h), at 21 ± 0.5°C and 50-60% humidity conditions. The mice were fed autoclaved foodstuff and water ad libitum. Females were kept in solid bottom polycarbonate cages with stainless steel wire lids (Nalgene; Cat No: 662-2150) . Autoclaved wood pellets were used as bedding material and bedding was changed once a week. Females were superovulated by intraperitoneal (i.p.) injections of 5 IU pregnant mare serum gonadotropin (PMSG; Sigma; G-4877) at 13:00 h, followed by an i.p. injection of 5 IU human chorionic gonadotropin (hCG; Pregnyl, Organon) 48 h later, then placed individually with stud males (Hogan et al. 1994 , Bagis et al. 2002a ). Successfully-mated females were identi ed by vaginal plugs (Day 0). Oviducts were excised, and cumulus oocyte complexes (COCs) were released from oviductal ampullae, then transferred into drops of M2 medium containing 80 IU/ml hyaluronidase (H-3506, Sigma) for 3 min. One-cell stage embryos were collected 23 h post-hCG. Finally, all embryos were washed three times in M2 medium, and zygotes were selected under an inverted Zeiss DIC microscope (Axiovert 35 M) at 200 magni cation for the presence of the second polar body and two pronuclei.
Preparation of foster mothers and ET
Embryo transfer recipients were 10-12week-old females of CD-1 strain with 28-35 g body weight. Foster mothers were prepared by introducing them to vasectomized males (two foster mothers to one vasectomized CB6F1 male) one day before the transfer. Females were checked for a vaginal plug, and those with a vaginal plug were separated for ET. The next morning, females having a vaginal plug were determined and designated as '0.5-day foster mothers'. For each experimental trial, 13 recipients were used for ET. Embryo transfer procedures were performed between 11:00 and 12:00 h in an operation room at 21 ± 0.5°C. On the day of surgery the mice were weighed and females having a vaginal plug were anaesthetized with a combination of 10 mg/kg xylazine (Rompun; Bayer, Germany), 80-100 mg/kg ketamine hydrochloride (Ketamidor 10%; Richter Pharma AG, Germany) or with 0.015-0.017 ml of 2.5% tribromoethanol (Aldrich T4,840-2) per gram of body weight, administered intraperitoneally. Then the right ovary and oviduct were externalized through a lateral section opened under the last rib on the back. Under dissection microscope (SV8, Zeiss), the ampullae region of the oviducts was secured with a serre ne clamp attached to the fat pad, and a hole was made with a 30-gauge needle (Becton Dickinson & Co.) in the region between the infundibulum and the ampulla. An M2 solution column (2 l) with 15-30 zygotes was loaded between two air bubbles within a 120 m diameter transfer capillary then transferred into the ampulla through the opening mentioned above, until the two air bubbles were visible in the oviduct. (Hogan et al. 1994 , Pinkert 1994 , Bagis et al. 2002b ). After ET, each mouse was separately placed in a cage supplied with ad libitum foodstuff and water and kept separate until the study was completed. The cages containing one mouse in each were immediately transferred into an incubator (Kerman Co. Turkey). Adequate ventilation was assured by leaving the door ajar, the temperature inside the incubator varied between 33 and 35°C. Control animals were kept in the operation room overnight without any warming (at 21 ± 0.5°C). Next morning all cages from both groups were transferred to the animal house and kept until Day 15, when all foster mothers were sacri ced by cervical dislocation. Macroscopic examination was carried out to detect any gross lesions of the ovaries, oviducts and uterine horns; and to record implantation sites, resorptions and normal fetuses.
Experimental design
In Experiment 1, the CD-1 foster mothers anaesthetized with the ketamine and xylazine combination were kept either in an incubator or at room temperature (RT) after the ET. In Experiment 2, the same design was repeated with tribromoethanol as the anaesthetic. A total of 1057 presumptive zygotes were transferred into 52 foster mothers. Females of all treatment groups were sacri ced on the 15th day of pregnancy, and fetal development was recorded, as described above.
Statistical analysis
In the present study animals were randomly assigned to treatment groups and experiments were replicated four times. Data were analysed by Chi-square test using the Graphad Software Program (Minolta, version 2.02, Dr. Granger, LSU Medical Center). Correlation analysis (Spearman Rank correlation coef cient) using SSPS 10.0 for Windows (SSPS Inc, Chicago, IL, USA) was used to assess the relationship between the numbers of transferred embryos and pregnancy rates.
Results
Pathological examinations on Day 15 did not reveal any gross lesions of the genital tracts in any of the foster mothers. In the rst part of the study, foster mothers were anaesthetized by ketamine/xylazine combination for ET and immediately after that operation were kept at either RT or in an incubator. Pregnancy rates for the RT and the incubator groups were statistically not different (69% (9/13) vs 92% (12/13), respectively). However, signi cant differences were found in implantation, development to normal fetuses and resorption rates between the RT and the incubator groups (Table 1, 30% vs 52% (P 0.001), 24% vs 51% (P 0.001), 6% vs 1% (P 0.01), respectively).
In the second experiment, tribromoethanol was used for anaesthesia. Pregnancy rates between the two postoperative temperature groups were signi cantly different (46.2% (6/13) for RT vs 100% (13/13) for incubator groups, respectively; P 0.01). There were statistically signi cant differences in the rates of implantation and development to normal fetuses between RT and incubator groups (Table 2, 12% vs 58% (P 0.001); 10% vs 55% (P 0.001); respectively). In addition, our results showed that in the RT groups following the use of ketamine/ xylazine, signi cantly higher rates of implantation, resorption and development to normal fetus were found compared to that with tribromoethanol. In contrast there were no statistically signi cant differences between the groups of ketamine/xylazine and tribromoethanol-treated mice that were subsequently placed into an incubator. In some cases implantation sites, resorptions and normal fetuses were found within the same individuals ( ve females in the ketamine/xylazine and RT; three in the ketamine/xylazine and incubator; four in the tribomoethanol and RT and four in the tribomoethanol and incubator groups, respectively). No statistical differences in pregnancy rates were detected among the females in the treatment groups. In addition, we did not detect any statistically significant correlation between the number of transferred embryos and pregnancy rates (data not shown).
Discussion
Our data showed that exposure to a warmer temperature can signi cantly increase the ef ciency of ET, probably due to negation of the hypothermia caused by both anaesthetics after ET. The results demonstrate the huge impact of the ET step on the overall ef ciency of embryo technologies. Side effects of anaesthetics are of high importance. Previous studies indicated that hypothermia occurs after anaesthesia possibly as a result of decreased heat production and/or increased heat loss (Lin et al. 1987) . Tribromoethanol is a commonly used anaesthetic for ET to generate transgenic mice by numerous transgenic core facilities (Robertson 1987 , Pinkert 1994 , Bagis et al. 2002a . Besides hypothermia, it has been reported to cause peritonitis in some cases, while ketamine/xylazine has been considered safer from this point of view (Zeller et al. 1998) , and others have found tribromoethanol to be safe and without side effects (Weiss & Zimmerman 1999) . Some reports detected no differences in the success rate of ET using either tribromoethanol or the ketamine mixtures (Weiss & Zimmerman 1999) . We could not detect any pathological defects in the uterine horns, oviducts and ovaries on Day 15 in any of the recipient females. Tribromoethanol with room temperature recovery resulted in lower implantation and total development rates than ketamine/ xylazine; however, this difference disappeared with postoperative recovery in an incubator. This might indicate that the reduction in success rates with tribromoethanol was due to a stronger hypothermia-inducing side effect of this drug. Keeping animals in an incubator after ET is a safe method for warming them up and maintaining their body temperature. Other alternatives to maintaining the body temperature of operated animals are their insulation from the cool surgical table surface, and if possible, their grouping during recovery. As we did not perform any postoperative warming in the RT groups, the side effects of tribromoethanol might have been increased in our experiments, which probably explains our relatively low implantation rates compared to those of others (Zeller et al. 1998 ). Furthermore, our data showed that within the range of embryos transferred in our experiments (15-30 zygotes/ recipient) there was no correlation between the number of transferred embryos and pregnancy rates in any of the treatment groups.
In conclusion, our results showed that exposing the foster mothers to an increased temperature after ET signi cantly improved ef ciency, by negating some of the side effects of both the anaesthetic drug combinations tested.
